+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Viscosupplementation Market by Product (Five Injection, Single Injection, Three Injection), Source (Animal, Non-animal), Application, End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 189 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 4986027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Viscosupplementation Market grew from USD 2.83 billion in 2023 to USD 3.01 billion in 2024. It is expected to continue growing at a CAGR of 6.19%, reaching USD 4.32 billion by 2030.

As a non-surgical treatment option, viscosupplementation aims to improve joint function, reduce pain, and possibly delay joint replacement surgery. Increasing incidences of joint disorders and sport-related injuries, a growing elderly population that is more susceptible to such ailments, and the rising preference for minimally invasive procedures significantly contribute to market growth. However, the existence of alternative treatment options, including steroid injections and non-pharmacologic therapies, may impede market growth. Nevertheless, technological advancements in formulating and delivering hyaluronic acid and healthcare infrastructure improvements are expected to create potential opportunities for developing the viscosupplementation market.

Regional Insights

The market is evolving in the Americas owing to the growing incidence of osteoarthritis, high healthcare expenditure, increasing preference for minimally invasive procedures, and widespread availability of several FDA-approved HA products. Advanced healthcare systems, increased awareness about osteoarthritis treatment options, and supportive regulatory frameworks are encouraging the growth of the viscosupplementation market in Europe. The Middle East and Africa viscosupplementation market is growing with improving availability and affordability of treatment and the prevalence of competitive treatment modalities for osteoarthritis. The Asia Pacific region represents significant demand for viscosupplementation due to high osteoarthritis prevalence, expanding healthcare infrastructure, and increasing accessibility to advanced osteoarthritis treatments. Besides, ongoing research to improve the efficacy of viscosupplementation therapy is anticipated to propel the demand for the viscosupplementation market globally.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Viscosupplementation Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Growing Need for Non-Surgical Treatment for Osteoarthritis
  • Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
  • Surge in Geriatric Population and Obesity Globally

Market Restraints

  • Side Effects and High Cost of The Hyaluronic Acid-Based Treatment

Market Opportunities

  • Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
  • Extending Role of Viscosupplementation in Patellar Chondropathy

Market Challenges

  • Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief

Market Segmentation Analysis

  • Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis
  • Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks
  • Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis
  • End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Viscosupplementation Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Viscosupplementation Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis

Kiomed Pharma and ARSYLAB have entered a strategic partnership to promote and distribute KIOMEDINEVS.ONE, a breakthrough treatment class for individuals suffering from refractory knee osteoarthritis in France. This innovative therapy represents a new direction in viscosupplementation, offering a promising option for patients.

Anika’s Cingal Successfully Achieves Primary Endpoint in Third Phase III Study

Anika Therapeutics completed a Phase 3 clinical trial for its innovative product, CINGAL. CINGAL is specifically formulated to provide effective treatment for the symptoms of osteoarthritis through intra-articular viscosupplementation. The primary endpoint of the study clearly demonstrated that a single intra-articular injection of CINGAL outperformed placebo in improving patient symptom scores at the 24-week mark.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Viscosupplementation Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Viscosupplementation Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Anika Therapeutics, Inc., Avanos Medical, Inc., Bausch Health Companies Inc., Bioventus LLC, Contipro A.S., DePuy Synthes by Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Ferring B.V., Fidia Farmaceutici S.p.A., Gentex Pharma, LLC, LG Chem Ltd., Lifecore Biomedical, LLC, Quimfa S.A., Regen Lab SA, Sanofi S.A., Seikagaku Corporation, Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Viatris Inc., and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Viscosupplementation Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

  • Five Injection
  • Single Injection
  • Three Injection

Source

  • Animal
  • Non-animal

Application

  • Hand Osteoarthritis
  • Hip Osteoarthritis
  • Knee Osteoarthritis

End-use

  • Hospitals
  • Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing Need for Non-Surgical Treatment for Osteoarthritis
5.1.1.2. Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
5.1.1.3. Surge in Geriatric Population and Obesity Globally
5.1.2. Restraints
5.1.2.1. Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
5.1.3. Opportunities
5.1.3.1. Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
5.1.3.2. Extending Role of Viscosupplementation in Patellar Chondropathy
5.1.4. Challenges
5.1.4.1. Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief
5.2. Market Segmentation Analysis
5.2.1. Products: Burgeoning adoption of a three-injection regimen to reduce pain and enhance mobility in patients with osteoarthritis
5.2.2. Source: Growing preference for non-animal-based hyaluronic acid as it eliminates hypersensitivity reaction risks
5.2.3. Applications: Evolving applications of viscosupplementation treatment for knee osteoarthritis
5.2.4. End-use: Proliferating utilization of viscosupplementation treatment in orthopedic clinics/ambulatory surgical centers (ASCs)
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
6. Viscosupplementation Market, by Product
6.1. Introduction
6.2. Five Injection
6.3. Single Injection
6.4. Three Injection
7. Viscosupplementation Market, by Source
7.1. Introduction
7.2. Animal
7.3. Non-animal
8. Viscosupplementation Market, by Application
8.1. Introduction
8.2. Hand Osteoarthritis
8.3. Hip Osteoarthritis
8.4. Knee Osteoarthritis
9. Viscosupplementation Market, by End-use
9.1. Introduction
9.2. Hospitals
9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
10. Americas Viscosupplementation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Viscosupplementation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Viscosupplementation Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis
13.3.2. Anika’s Cingal Successfully Achieves Primary Endpoint in Third Phase III Study
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. VISCOSUPPLEMENTATION MARKET RESEARCH PROCESS
FIGURE 2. VISCOSUPPLEMENTATION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VISCOSUPPLEMENTATION MARKET DYNAMICS
FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON-ANIMAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 45. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 46. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 47. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 48. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 53. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 54. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 61. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 64. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 65. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 68. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 69. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 72. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 73. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 76. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 90. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 97. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 98. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 99. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 100. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 105. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 106. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 107. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 108. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 109. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 110. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 111. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 112. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 113. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 116. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 117. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 120. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 121. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 122. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 123. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 124. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 129. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 130. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 131. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 132. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 133. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 134. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 135. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 136. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 137. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 140. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 145. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 146. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 147. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 148. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 153. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 154. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 155. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 156. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 161. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 164. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 169. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 172. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 177. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 178. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 179. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 180. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 181. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 184. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 185. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 186. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 187. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 188. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 203. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 204. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 205. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 206. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 207. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 210. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 211. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 214. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 215. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 218. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 219. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 220. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 221. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 222. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 223. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 226. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 227. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 228. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 229. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 230. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 231. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 232. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 233. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 234. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 235. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 238. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 239. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 242. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 243. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 244. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 245. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 246. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 251. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 254. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 255. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 258. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 259. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 262. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 267. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 268. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 269. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 270. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 275. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 278. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 279. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 282. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 283. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 284. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 285. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 286. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 287. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 290. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 291. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 292. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 293. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 294. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 295. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 296. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 297. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 298. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 299. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 300. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 301. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 302. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 308. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 310. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 316. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 318. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 320. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 322. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 323. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 324. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 325. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 326. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 327. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 328. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 329. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 330. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 331. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 332. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 333. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 334. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 335. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 336. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 337. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 338. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 339. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 340. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 341. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 342. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 343. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 344. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 345. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 346. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 347. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 348. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 349. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 350. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 351. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 352. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 353. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
TABLE 354. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
TABLE 355. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2024-2030

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Alcon Inc.
  • Anika Therapeutics, Inc.
  • Avanos Medical, Inc.
  • Bausch Health Companies Inc.
  • Bioventus LLC
  • Contipro A.S.
  • DePuy Synthes by Johnson & Johnson Services, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ferring B.V.
  • Fidia Farmaceutici S.p.A.
  • Gentex Pharma, LLC
  • LG Chem Ltd.
  • Lifecore Biomedical, LLC
  • Quimfa S.A.
  • Regen Lab SA
  • Sanofi S.A.
  • Seikagaku Corporation
  • Smith & Nephew PLC
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zimmer Biomet

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.01 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.32 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal

Related Topics

Related Reports

Viscosupplementation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Viscosupplementation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Hyaluronic Acid Viscosupplementation - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Hyaluronic Acid Viscosupplementation - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Viscosupplementation Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Image

Viscosupplementation Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • 200 Pages
  • Global
From
Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2024-2032 - Product Image

Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2024-2032

  • Report
  • 149 Pages
  • Global
From
Viscosupplementation Global Market Report 2024 - Product Image

Viscosupplementation Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From

About the Market

Viscosupplementation is a type of orthopedic device used to treat joint pain caused by osteoarthritis. It involves injecting a gel-like substance, known as a viscosupplement, into the affected joint. The viscosupplement is designed to lubricate the joint and reduce pain and inflammation. It is typically used when other treatments, such as physical therapy and medications, have not been successful. Viscosupplementation is a relatively new technology and is becoming increasingly popular as an alternative to more invasive treatments, such as joint replacement surgery. It is generally considered to be safe and effective, with few side effects. Some of the companies in the viscosupplementation market include Zimmer Biomet, Smith & Nephew, Stryker, and DePuy Synthes. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.